Skip to main content
logo
Sonnet BioTherapeutics Holdings, Inc. (SONN)
NASDAQ: SONN · Real-Time Price · USD
2.940
+0.060 (2.08%)
Aug 8, 2025, 11:49 AM - Market open

Revenue by Product

Fiscal year is October - September.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Sep '24 Sep '23 Sep '22 Sep '21 Dec '19 2017 - 2019
Immuno-oncology Treatments
18.63K
Log In
Log In
Log In
Log In
Upgrade
Immuno-oncology Treatments Growth
-87.40%
Log In
Log In
Log In
Log In
Upgrade
Restaurant
-
Log In
Log In
Log In
Log In
Upgrade
Franchise
-
Log In
Log In
Log In
Log In
Upgrade
Gaming
-
Log In
Log In
Log In
Log In
Upgrade
Management Fee Income
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is October - September.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Sep '24 Sep '23 Sep '22 Sep '21 Dec '19 2017 - 2019
United States
18.63K
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-87.40%
Log In
Log In
Log In
Log In
Upgrade
United States and United Kingdom
-
Log In
Log In
Log In
Log In
Upgrade